Microsoft co-founder Bill Gates has provided funding for the development of a new COVID-19 vaccine, SKYCovion, which has recently gained regulatory approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA). The vaccine is now authorized for use in multiple countries globally, with a particular focus on underdeveloped nations.

Developed in South Korea, SKYCovion combines a portion of the SARS-CoV-2 virus spike protein with GSK’s AS03 adjuvant technology in a self-assembled nanoparticle vaccine. However, it is important to note that the MHRA has highlighted several critical points regarding the vaccine’s use and limitations.

https://beckernews.com/bill-gates-gets-fast-track-approval-for-a-new-covid-19-vaccine-despite-serious-safety-concerns-50698/